An intercontinental comparison of the influence of smoking on the occurrence of nonsyndromic cleft lip and palate: a meta-analysis and systematic review

Article information

Arch Craniofac Surg. 2024;25(2):51-61
Publication date (electronic) : 2024 April 20
doi : https://doi.org/10.7181/acfs.2023.00437
1Department of Burns and Plastic Surgery, All India Institute of Medical Sciences, Rishikesh, India
2Department of Biochemistry, King George’s Medical University, Lucknow, India
3Department of Biochemistry, All India Institute of Medical Sciences, Rishikesh, India
4Department of Cranio-Maxillofacial Surgery, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands
Correspondence: Madhubari Vathulya Department of Burns and Plastic Surgery, All India Institute of Medical Sciences, Rishikesh, Uttarakhand 248001, India E-mail: madhubari@yahoo.co.in
Received 2023 September 11; Revised 2023 September 11; Accepted 2023 November 6.

Abstract

Background

The influence of smoking on nonsyndromic clefts has been a topic of research for many years. However, few studies have investigated the effect of smoking on causing clefts in different gene pools.

Methods

A meta-analysis was conducted of case-control studies related to smoking. Keywords such as “clefts,” “cleft lip,” “cleft palate,” “orofacial cleft,” and “smoking” were used to search the MEDLINE, Embase, and Cochrane databases.

Results

In total, 51 articles were reviewed. The RevMan software was utilized for the analysis, and the Mantel-Haenszel method was employed to pool the odds ratios (ORs) and 95% confidence intervals. Although the overall OR, a measure of the association between exposure and outcome, was higher for smokers than for non-smokers, this association was significantly stronger in individuals from Asia and South America (1.73), and lowest in Europe (1.31). Among active and passive smokers in Asia, the OR was approximately 0.93, indicating an equivalent impact from both types of smoking.

Conclusion

This analysis indirectly suggests that restriction measures targeting both active and passive smoking are crucial in Asia.

INTRODUCTION

Maternal smoking has various impacts on the fetus, but it is not always clear whether a mother has engaged in smoking or been exposed to tobacco. Some research has explored the significance of the dose-dependent effect of tobacco on cleft conditions, a category of severe congenital abnormalities. Although systematic reviews and meta-analyses have previously been conducted on this association, it is crucial to re-evaluate the data, incorporating all studies, including recent ones, to enhance our existing understanding. Given the multifactorial etiology of cleft conditions, this study aimed to conduct an intercontinental subgroup analysis of currently available data. Additionally, we aimed to investigate potential genetic influences on the occurrence of cleft conditions among mothers exposed to tobacco. The assumption underlying this review was that a study conducted on a specific continent was likely to primarily reflect the gene pool of that continent.

MATERIALS AND METHODS

The search strategy was as follows: we searched for articles that discussed the impact of smoking prior to and during the first trimester of pregnancy on the occurrence of clefts (periconceptual period). Search terms such as “clefts,” “cleft lip,” “cleft palate,” “orofacial cleft,” and “smoking” were used to identify studies in the MEDLINE, Embase, and Cochrane databases from 1989 to November 21, 2021. We limited the search to case-control designs. Further refinement of the articles was done using the filters “human subjects” and “articles for which a complete English translation can be retrieved.” All the articles were catalogued in Excel spreadsheets, and a PRISM diagram is shown in Fig. 1.

Fig. 1.

PRISM diagram.

The inclusion criteria were as follows: (1) studies that reported active and passive smoking, specifically focusing on women in the peri-conceptual period who are exposed to cigarette smoke by their partners or other close contacts, and analyzed the relationship between smoking (both active and passive) and nonsyndromic clefts through a comparison of the incidence in smokers and non-smokers; and (2) case-control studies that described both comparison and control groups.

The exclusion criteria were as follows: (1) studies that included smoking but did not specifically mention the association with clefts; (2) studies that included smoking but did not analyze the marginal effect on clefts, instead elaborating on the genetic modifications that led to clefts; or (3) studies that analyzed the association of smoking with syndromic clefts and studies from which data on nonsyndromic clefts could not be retrieved.

The following information was derived from the pooled data: (1) the prevalence of active and passive maternal smoking prior to and during the first trimester of pregnancy; (2) sample size, definitions of passive and active smoking, and base population; (3) study design; (4) study subtypes (and hence population subtypes) based on the continent where the study was conducted, presuming that a study from a particular continent would predominantly include a population originating from that continent; or (5) association between smoking and cleft lip and/or palate: odds ratios (ORs) and confidence intervals (CIs) without frequencies were included when available.

Quality of studies

The studies were categorized based on the Newcastle-Ottawa Scale into good, fair, and poor-quality studies. Those of poor quality were excluded from the analysis.

Risk of bias

The Newcastle-Ottawa Scale was employed to evaluate the risk of bias, as all the included studies were observational rather than randomized controlled trials. Further assessments were conducted using funnel plots and L’Abbé plots.

Small study effects

Funnel plots were utilized to visually represent the effects of small studies. This was done for all studies collectively, as well as for specific subsets, which dealt with the relationship between active and passive smoking with clefts, various types of clefts, and intercontinental studies.

Statistical analysis

We conducted a meta-analysis using the free software, ReviewManager (RevMan). The Mantel-Haenszel method was employed to combine studies and calculate summary ORs and 95% CIs for active or passive smoking. We tested for homogeneity and heterogeneity using the I2 statistic. A value exceeding 50% indicated moderate heterogeneity, while a value over 75% signified severe heterogeneity. For further analysis of the odds, we used a fixed-effect model for homogeneous studies and a random-effect model for heterogeneous studies. ORs, accompanied by 95% CIs, were graphically depicted in forest plots. Crude and adjusted ORs were calculated with 95% CIs. Further derivations were conducted using inverse variance weights and restricted maximum likelihood.

Subgroup analyses

Subgroup analyses were conducted according to the type of clefts, the type of smoking, and the continent from which the sample population was selected (i.e., the population pool).

RESULTS

After applying filters such as “case-control studies,” “human,” and “English language” to the MEDLINE database, 621 articles were retrieved. A search of the Embase database yielded 19 articles. A search of the Cochrane database did not produce any suitable articles. Therefore, a total of 640 records were identified through database searching. Out of them, a total of 574 articles were gathered for review after removing duplicates and applying the inclusion and exclusion criteria. Each article was meticulously examined for relevant data, resulting in a final selection of 51 articles [1-51]. The search process was carried out by two authors (MV, NS). In instances where there was disagreement about the inclusion or exclusion of a particular article, a third author (PK) was consulted for resolution.

Smokers versus non-smokers and cleft occurrence

A total of 51 studies were included in the final analysis. The cumulative OR was 1.44 (95% CI, 1.24–1.67). The I2 test resulted in a value of 96.02%, indicating a high degree of heterogeneity among the studies, thus necessitating the application of a random-effect model. The value of τ2 was 0.25 (Fig. 2). Both funnel plots and L’Abbé plots were generated to assess the likelihood of publication bias.

Fig. 2.

Forest plot of the association between smoking (vs. non-smoking) and cleft occurrence.

Active versus passive smoking and cleft occurrence

We shortlisted six relevant studies that provided details on active and passive smokers in relation to cleft occurrence. The combined OR was 1.11 (95% CI, 0.87–1.41). The I2 value demonstrated homogeneity, as indicated by a value of 28.53% (Fig. 3).

Fig. 3.

Forest plot of the association between active versus passive smoking and cleft occurrence.

Influence of the continent on clefts among smokers

Data regarding the continent of origin were available for 51 studies. The studies were conducted in Asia (15 studies), Europe (10 studies), North America (20 studies), and South America (3 studies), and three studies spanned multiple continents. The cumulative OR from multicontinental data was 1.52 (95% CI, 0.95–2.41). For Asia, the OR was 1.75 (95% CI, 1.15–2.65). Europe had an OR of 1.31 (95% CI, 1.06–1.63), while that of North America was 1.34 (95% CI, 1.21−1.49). Lastly, South America had an OR of 1.78 (95% CI, 1.39−2.28) (Fig. 4).

Fig. 4.

Active versus passive smoking according to continent.

Active versus passive smoking according to continent

The cumulative OR for Asia was 0.93, while the rest of the continents had ORs exceeding 1 (Fig. 5).

Fig. 5.

Active versus passive smoking according to continent.

Smokers versus non-smokers and subgroups of clefts

Three studies that included cleft lips yielded an OR of 1.71 (95% CI, 0.54–5.39). Eighteen studies specifically included cleft palate patients, with an OR of 0.89 (95% CI, 0.68–1.16). Additionally, 16 studies focused on patients with both cleft lip and palate (OR, 0.83; 95% CI, 0.46–1.51). This analysis indicated that smoking had a greater influence on cleft lip (as shown in Fig. 6) than on cleft palate (Fig. 7) or cleft lip with palate (Fig. 8).

Fig. 6.

Forest plot of the association between smoking (vs. non-smoking) and cleft lip.

Fig. 7.

Forest plot of the association between smoking (vs. non-smoking) and cleft palate.

Fig. 8.

Forest plot of the association between smoking (vs. non-smoking) and cleft lip with palate.

Summary of results

Smokers vs. non-smokers

Figs. 1 and 2 demonstrate that children born to smokers (OR, 1.44; 95% CI, 1.24–1.67) were more likely to have cleft lip or cleft palate than children born to non-smokers. The study results exhibited a significantly high level of heterogeneity, with an I2 value of 96%. A subgroup analysis by continent did not reduce this heterogeneity. The association was stronger in studies reported from Asia and South America, with pooled ORs of 1.75 and 1.78, respectively. Conversely, studies from Europe presented the lowest OR of 1.31. The symmetry of the funnel plot suggests the absence of a small study effect in our analysis.

Active vs. passive smokers

Fig. 3 illustrates that active smokers exhibited 1.11 times higher odds of developing cleft lip or cleft palate than passive smokers (OR, 1.11; 95% CI, 0.87−1.41). However, this association was not statistically significant. The studies demonstrated low heterogeneity (I2= 29%).

Cleft lip only

Children born to smokers were found to have higher odds of developing cleft lip (OR, 1.71; 95% CI, 0.54–5.39); however, this association was not statistically significant. It should be noted, though, that only three studies reported this outcome, and moderate heterogeneity was observed among these studies.

Cleft palate only

The relationship between smoking and cleft palate was not found to be significant (OR, 0.89; 95% CI, 0.68–1.16). There was a significantly high level of heterogeneity among the studies (I2= 94%). The symmetry of the funnel plot suggests the absence of publication bias.

Cleft lip and palate

Children born to smokers were found to have a lower likelihood of developing cleft lip and palate than those born to non-smokers (OR, 0.83; 95% CI, 0.46–1.51). However, this association was not statistically significant. The study results exhibited high heterogeneity. The funnel plot was asymmetrical, with some studies reporting a highly significant protective effect of smoking.

DISCUSSION

Nonsyndromic clefts account for 70% of all reported cleft cases. Their etiology can be attributed to both genomic factors and epigenomic modifications. Genetic factors include MSX, IRF-6, FOX E, TGF-β, and others [52], and epigenomic influences from folate [53], smoking [54], and other factors have also been described.

Epigenetic factors such as cessation of smoking [55], vitamin supplement intake, calcium intake, and environmental pollution, play a crucial role in prevention. These factors are of particular importance because they are modifiable, unlike genetic factors.

Nicotine in tobacco is implicated in causing clefts through several mechanisms. Primarily, its vasoconstrictive effect can decrease uterine blood flow and oxygen delivery to the developing fetus, thereby disrupting both neural development and palatal fusion [56]. Additionally, nicotine may directly affect cleft palate by altering gene expression [57], which can lead to the persistence of epithelial cells in areas where connective tissue should fuse.

Thus, smoking cessation can be highly effective as a strategy to prevent clefts. A quantitative assessment of the association with clefts can provide caregivers and health workers with real-time data to emphasize when educating individuals about the benefits of quitting smoking. Although several systematic reviews and meta-analyses have explored this topic, their results have largely been inconsistent. These studies have typically focused on either active or passive smoking. Despite acknowledging the potential for heterogeneity bias in their research, these studies have not eliminated one of the most significant preventable causes of this issue—namely, the broad, non-specific genetic pool of the population studied. While smoking is a common etiological factor, different genetic pools may have varying susceptibilities to nicotine, and therefore, may not all have the same risk of developing clefts.

The proportion of active to passive smoking varies in different parts of the world [58]. For example, in Western countries, it is relatively common for women to smoke, unlike in certain Asian countries, where it is considered taboo for women to do so. Therefore, it is reasonable to anticipate that the susceptible female population in these countries, and consequently the continent, is more exposed to passive smoking than active smoking. While acknowledging the potential difficulty in eliminating genetic bias due to the dynamic population exchange among various countries, the authors of this study have nonetheless endeavored to further subanalyze the pooled data based on the continents of origin of the patients included in these studies. Nonetheless, a key assumption here is that the genetic pool included in a specific study corresponds to the same continent where the study was conducted.

Our analysis has demonstrated that smoking is a risk factor, as evidenced by the cumulative odds ratio of 1.44 for clefts, consistent with previous studies such as Crossan and Duane [59], which stated that the OR was 1.368 for cleft lip and/or cleft palate and 1.241 for cleft palate in actively smoking mothers. The high heterogeneity of the data could have been due to differences in the prevalence of smoking among different populations.

The results of a sub-analysis of the data by continent consistently indicated that smoking was a risk factor in all populations considered in the study, including those in Asia, Europe, and North and South America. Furthermore, the study demonstrated that active smoking poses a greater risk than passive smoking, with an OR of 1.11. This finding aligns with the conclusions drawn by Honein et al. [19].

However, the intercontinental analysis of active and passive smoking revealed no significant difference (with an OR of less than 1) in the Asian population compared to those in Europe, North, or South America (where the OR was more than 1). Despite the limited number of studies included in this analysis, there is essentially no evidence that would support dismissing the potential effects of passive smoking in causing clefts among populations in continents such as Asia.

The study conducted by Ma et al. [60] showed that there has been an increase in passive or secondhand smoke exposure in Asian countries. Despite smoking bans, compliance in middle and low-income countries (such as many of those in Asia) has not decreased as significantly as in other regions, due to political or economic factors. The impact of passive smoking on the occurrence of nonsyndromic clefts has been found to be greater than that of active smoking, as documented in the systematic review by Sabbagh et al. [61]. Since Asia is in the initial stages of the tobacco smoking epidemic [62], stricter restrictions need to be implemented on both active and passive smoking to prevent clefts, particularly in these regions.

A sub-analysis of the types of clefts identified smoking as a definitive risk factor for pure cleft lip, as compared to cleft palate or cleft lip with palate (with ORs of 1.71 versus 0.89 and 0.83). This finding contrasts with the study conducted by Kummet et al. [63], in which the OR was 1.16 for all subtypes of clefts.

CONCLUSION

This meta-analysis indicates that smoking is a risk factor for the development of clefts. It further demonstrates that the impact of both types of smoking is particularly detrimental to the Asian population, to a greater extent than for populations from Europe, North America, and South America.

Notes

Conflict of interest

No potential conflict of interest relevant to this article was reported.

Funding

This review was supported from Maastricht Educational and Research Centre Pvt Ltd.

Author contributions

Conceptualization: Madhubari Vathulya, Neetu Singh, Manisha Naithani, Peter Kessler. Data curation; Formal analysis; Funding acquisition: Madhubari Vathulya. Methodology: Madhubari Vathulya, Neetu Singh, Manisha Naithani. Project administration: Peter Kessler. Writing - original draft: Madhubari Vathulya. Resources; Software: Madhubari Vathulya. Supervision: Peter Kessler. Validation: Manisha Naithani.

References

1. Acs L, Banyai D, Nemes B, Nagy K, Acs N, Banhidy F, et al. Maternal-related factors in the origin of isolated cleft palate: a population-based case-control study. Orthod Craniofac Res 2020;23:174–80.
2. Angulo-Castro E, Acosta-Alfaro LF, Guadron-Llanos AM, Canizalez-Roman A, Gonzalez-Ibarra F, Osuna-Ramirez I, et al. Maternal risk factors associated with the development of cleft lip and cleft palate in Mexico: a case-control study. Iran J Otorhinolaryngol 2017;29:189–95.
3. Auslander A, McKean-Cowdin R, Brindopke F, Sylvester B, DiBona M, Magee K, et al. The role of smoke from cooking indoors over an open flame and parental smoking on the risk of cleft lip and palate: a case-control study in 7 low-resource countries. J Glob Health 2020;10:020410.
4. Bille C, Olsen J, Vach W, Knudsen VK, Olsen SF, Rasmussen K, et al. Oral clefts and life style factors: a case-cohort study based on prospective Danish data. Eur J Epidemiol 2007;22:173–81.
5. Bui AH, Ayub A, Ahmed MK, Taioli E, Taub PJ. Association between cleft lip and/or cleft palate and family history of cancer: a case-control study. Ann Plast Surg 2018;80(4 Suppl 4):S178–81.
6. Bui AH, Ayub A, Ahmed MK, Taioli E, Taub PJ. Maternal tobacco exposure and development of orofacial clefts in the child: a case-control study conducted in Pakistan. Ann Plast Surg 2018;81:708–14.
7. Carmichael SL, Shaw GM, Yang W, Abrams B, Lammer EJ. Maternal stressful life events and risks of birth defects. Epidemiology 2007;18:356–61.
8. Carmichael SL, Yang W, Feldkamp ML, Munger RG, Siega-Riz AM, Botto LD, et al. Reduced risks of neural tube defects and orofacial clefts with higher diet quality. Arch Pediatr Adolesc Med 2012;166:121–6.
9. Cedergren M, Kallen B. Maternal obesity and the risk for orofacial clefts in the offspring. Cleft Palate Craniofac J 2005;42:367–71.
10. Chung KC, Kowalski CP, Kim HM, Buchman SR. Maternal cigarette smoking during pregnancy and the risk of having a child with cleft lip/palate. Plast Reconstr Surg 2000;105:485–91.
11. DeRoo LA, Gaudino JA, Edmonds LD. Orofacial cleft malformations: associations with maternal and infant characteristics in Washington State. Birth Defects Res A Clin Mol Teratol 2003;67:637–42.
12. Desrosiers TA, Lawson CC, Meyer RE, Richardson DB, Daniels JL, Waters MA, et al. Maternal occupational exposure to organic solvents during early pregnancy and risks of neural tube defects and orofacial clefts. Occup Environ Med 2012;69:493–9.
13. Dien VH, McKinney CM, Pisek A, Pitiphat W. Maternal exposures and risk of oral clefts in South Vietnam. Birth Defects Res 2018;110:527–37.
14. Elbourne D, Mutch L, Dauncey M, Campbell H, Samphier M. Debendox revisited. Br J Obstet Gynaecol 1985;92:780–5.
15. Ericson A, Kallen B, Westerholm P. Cigarette smoking as an etiologic factor in cleft lip and palate. Am J Obstet Gynecol 1979;135:348–51.
16. Figueiredo JC, Ly S, Magee KS, Ihenacho U, Baurley JW, Sanchez-Lara PA, et al. Parental risk factors for oral clefts among Central Africans, Southeast Asians, and Central Americans. Birth Defects Res A Clin Mol Teratol 2015;103:863–79.
17. Grewal J, Carmichael SL, Ma C, Lammer EJ, Shaw GM. Maternal periconceptional smoking and alcohol consumption and risk for select congenital anomalies. Birth Defects Res A Clin Mol Teratol 2008;82:519–26.
18. Hao Y, Tian S, Jiao X, Mi N, Zhang B, Song T, et al. Association of parental environmental exposures and supplementation intake with risk of nonsyndromic orofacial clefts: a case-control study in Heilongjiang Province, China. Nutrients 2015;7:7172–84.
19. Honein MA, Rasmussen SA, Reefhuis J, Romitti PA, Lammer EJ, Sun L, et al. Maternal smoking and environmental tobacco smoke exposure and the risk of orofacial clefts. Epidemiology 2007;18:226–33.
20. Hong Y, Xu X, Lian F, Chen R. Environmental risk factors for nonsyndromic cleft lip and/or cleft palate in Xinjiang Province, China: a multiethnic study. Cleft Palate Craniofac J 2021;58:489–96.
21. Ittiwut R, Siriwan P, Suphapeetiporn K, Shotelersuk V. Epidemiology of cleft lip with or without cleft palate in Thais. Asian Biomed 2017;10:335–8.
22. Jia ZL, Shi B, Chen CH, Shi JY, Wu J, Xu X. Maternal malnutrition, environmental exposure during pregnancy and the risk of non-syndromic orofacial clefts. Oral Dis 2011;17:584–9.
23. Khoury MJ, Weinstein A, Panny S, Holtzman NA, Lindsay PK, Farrel K, et al. Maternal cigarette smoking and oral clefts: a population-based study. Am J Public Health 1987;77:623–5.
24. Krajewski AK, Rappazzo KM, Langlois PH, Messer LC, Lobdell DT. Associations between cumulative environmental quality and ten selected birth defects in Texas. Birth Defects Res 2021;113:161–72.
25. Krapels IP, Zielhuis GA, Vroom F, de Jong-van den Berg LT, Kuijpers-Jagtman AM, van der Molen AB, et al. Periconceptional health and lifestyle factors of both parents affect the risk of live-born children with orofacial clefts. Birth Defects Res A Clin Mol Teratol 2006;76:613–20.
26. Lebby KD, Tan F, Brown CP. Maternal factors and disparities associated with oral clefts. Ethn Dis 2010;20(1 Suppl 1):S1–146.
27. Leite IC, Koifman S. Oral clefts, consanguinity, parental tobacco and alcohol use: a case-control study in Rio de Janeiro, Brazil. Braz Oral Res 2009;23:31–7.
28. Li Z, Liu J, Ye R, Zhang L, Zheng X, Ren A. Maternal passive smoking and risk of cleft lip with or without cleft palate. Epidemiology 2010;21:240–2.
29. Lieff S, Olshan AF, Werler M, Strauss RP, Smith J, Mitchell A. Maternal cigarette smoking during pregnancy and risk of oral clefts in newborns. Am J Epidemiol 1999;150:683–94.
30. Little J, Cardy A, Arslan MT, Gilmour M, Mossey PA; United Kingdom-Based Case-Control Study. Smoking and orofacial clefts: a United Kingdom-based case-control study. Cleft Palate Craniofac J 2004;41:381–6.
31. Liu Y, Wang B, Li Z, Zhang L, Liu J, Ren A. Indoor air pollution and the risk of orofacial clefts in a rural population in Shanxi province, China. Birth Defects Res A Clin Mol Teratol 2016;106:708–15.
32. Lorente C, Cordier S, Goujard J, Ayme S, Bianchi F, Calzolari E, et al. Tobacco and alcohol use during pregnancy and risk of oral clefts. Occupational Exposure and Congenital Malformation Working Group. Am J Public Health 2000;90:415–9.
33. Marshall EG, Harris G, Wartenberg D. Oral cleft defects and maternal exposure to ambient air pollutants in New Jersey. Birth Defects Res A Clin Mol Teratol 2010;88:205–15.
34. Martelli DR, Coletta RD, Oliveira EA, Swerts MS, Rodrigues LA, Oliveira MC, et al. Association between maternal smoking, gender, and cleft lip and palate. Braz J Otorhinolaryngol 2015;81:514–9.
35. McKinney CM, Pisek A, Chowchuen B, DeRouen T, Muktabhant B, Pradubwong S, et al. Case-control study of nutritional and environmental factors and the risk of oral clefts in Thailand. Birth Defects Res A Clin Mol Teratol 2016;106:624–32.
36. Mirilas P, Mentessidou A, Kontis E, Asimakidou M, Moxham BJ, Petropoulos AS, et al. Parental exposures and risk of nonsyndromic orofacial clefts in offspring: a case-control study in Greece. Int J Pediatr Otorhinolaryngol 2011;75:695–9.
37. Munger RG, Romitti PA, Daack-Hirsch S, Burns TL, Murray JC, Hanson J. Maternal alcohol use and risk of orofacial cleft birth defects. Teratology 1996;54:27–33.
38. Pi X, Li Z, Jin L, Liu J, Zhang Y, Zhang L, et al. Secondhand smoke during the periconceptional period increases the risk for orofacial clefts in offspring. Paediatr Perinat Epidemiol 2018;32:423–7.
39. Ramirez D, Lammer EJ, Iovannisci DM, Laurent C, Finnell RH, Shaw GM. Maternal smoking during early pregnancy, GSTP1 and EPHX1 variants, and risk of isolated orofacial clefts. Cleft Palate Craniofac J 2007;44:366–73.
40. Raut JR, Simeone RM, Tinker SC, Canfield MA, Day RS, Agopian AJ. Proportion of orofacial clefts attributable to recognized risk factors. Cleft Palate Craniofac J 2019;56:151–8.
41. Regina Altoe S, Borges AH, Neves AT, Aranha AM, Borba AM, Espinosa MM, et al. Influence of parental exposure to risk factors in the occurrence of oral clefts. J Dent (Shiraz) 2020;21:119–26.
42. Sabbagh HJ, Alamoudi NM, Abdulhameed FD, Innes NP, AlAama JY, Hummaida T, et al. Environmental risk factors in the etiology of nonsyndromic orofacial clefts in the western region of Saudi Arabia. Cleft Palate Craniofac J 2016;53:435–43.
43. Sato Y, Yoshioka E, Saijo Y, Miyamoto T, Sengoku K, Azuma H, et al. Population attributable fractions of modifiable risk factors for nonsyndromic orofacial clefts: a prospective cohort study from the Japan Environment and Children’s Study. J Epidemiol 2021;31:272–9.
44. Shaw GM, Nelson V, Carmichael SL, Lammer EJ, Finnell RH, Rosenquist TH. Maternal periconceptional vitamins: interactions with selected factors and congenital anomalies? Epidemiology 2002;13:625–30.
45. Suhl J, Romitti PA, Cao Y, Rocheleau CM, Burns TL, Conway K, et al. Maternal occupational cadmium exposure and nonsyndromic orofacial clefts. Birth Defects Res 2018;110:603–9.
46. Wehby GL, Uribe LM, Wilcox AJ, Christensen K, Romitti PA, Munger RG, et al. Interaction between smoking and body mass index and risk of oral clefts. Ann Epidemiol 2017;27:103–7.
47. Werler MM, Lammer EJ, Rosenberg L, Mitchell AA. Maternal cigarette smoking during pregnancy in relation to oral clefts. Am J Epidemiol 1990;132:926–32.
48. Wyszynski DF, Wu T. Use of US birth certificate data to estimate the risk of maternal cigarette smoking for oral clefting. Cleft Palate Craniofac J 2002;39:188–92.
49. Xu DP, Qu WD, Sun C, Cao RY, Liu DW, Du PG. A study on environmental factors for nonsyndromic cleft lip and/or palate. J Craniofac Surg 2018;29:364–7.
50. Zhang B, Jiao X, Mao L, Xue J. Cigarette smoke exposure before pregnancy and the associated risk of having a child with orofacial clefts in China: a case-control study. Plast Reconstr Surg 2011;127:61e–62e.
51. Zhang B, Jiao X, Mao L, Xue J. Maternal cigarette smoking and the associated risk of having a child with orofacial clefts in China: a case-control study. J Craniomaxillofac Surg 2011;39:313–8.
52. Stanier P, Moore GE. Genetics of cleft lip and palate: syndromic genes contribute to the incidence of non-syndromic clefts. Hum Mol Genet 2004;13 Spec No 1:R73–81.
53. Bianchi F, Calzolari E, Ciulli L, Cordier S, Gualandi F, Pierini A, et al. Environment and genetics in the etiology of cleft lip and cleft palate with reference to the role of folic acid. Epidemiol Prev 2000;24:21–7.
54. Panamonta O, Wiromrat P, Wongswadiwat Y, Chaikitpinyo A, Panamonta M, Wichajarn K. Maternal tobacco smoke exposure during pregnancy and the occurrence of orofacial clefts: a systematic review of reported meta-analyses. J Med Assoc Thai 2017;100(suppl 6):S270–7.
55. Diamanti A, Papadakis S, Schoretsaniti S, Rovina N, Vivilaki V, Gratziou C, et al. Smoking cessation in pregnancy: an update for maternity care practitioners. Tob Induc Dis 2019;17:57.
56. Shaw GM, Iovannisci DM, Yang W, Finnell RH, Carmichael SL, Cheng S, et al. Endothelial nitric oxide synthase (NOS3) genetic variants, maternal smoking, vitamin use, and risk of human orofacial clefts. Am J Epidemiol 2005;162:1207–14.
57. Kang P, Svoboda KK. Nicotine inhibits palatal fusion and modulates nicotinic receptors and the PI-3 kinase pathway in medial edge epithelia. Orthod Craniofac Res 2003;6:129–42.
58. Jafari A, Rajabi A, Gholian-Aval M, Peyman N, Mahdizadeh M, Tehrani H. National, regional, and global prevalence of cigarette smoking among women/females in the general population: a systematic review and meta-analysis. Environ Health Prev Med 2021;26:5.
59. Crossan E, Duane B. Is there an association between maternal smoking and oral clefts? Evid Based Dent 2018;19:24–5.
60. Ma C, Heiland EG, Li Z, Zhao M, Liang Y, Xi B. Global trends in the prevalence of secondhand smoke exposure among adolescents aged 12-16 years from 1999 to 2018: an analysis of repeated cross-sectional surveys. Lancet Glob Health 2021;9:e1667–78.
61. Sabbagh HJ, Hassan MH, Innes NP, Elkodary HM, Little J, Mossey PA. Passive smoking in the etiology of non-syndromic orofacial clefts: a systematic review and meta-analysis. PLoS One 2015;10e0116963.
62. Yang JJ, Yu D, Wen W, Shu XO, Saito E, Rahman S, et al. Tobacco smoking and mortality in Asia: a pooled meta-analysis. JAMA Netw Open 2019;2e191474.
63. Kummet CM, Moreno LM, Wilcox AJ, Romitti PA, DeRoo LA, Munger RG, et al. Passive smoke exposure as a risk factor for oral clefts: a large international population-based study. Am J Epidemiol 2016;183:834–41.

Article information Continued

Fig. 1.

PRISM diagram.

Fig. 2.

Forest plot of the association between smoking (vs. non-smoking) and cleft occurrence.

Fig. 3.

Forest plot of the association between active versus passive smoking and cleft occurrence.

Fig. 4.

Active versus passive smoking according to continent.

Fig. 5.

Active versus passive smoking according to continent.

Fig. 6.

Forest plot of the association between smoking (vs. non-smoking) and cleft lip.

Fig. 7.

Forest plot of the association between smoking (vs. non-smoking) and cleft palate.

Fig. 8.

Forest plot of the association between smoking (vs. non-smoking) and cleft lip with palate.